208
Participants
Start Date
June 1, 2024
Primary Completion Date
September 1, 2025
Study Completion Date
September 1, 2025
Iohexol
Subjects will receive a single bolus of 5 mL of Omnipaque 300 (containing 3235 mg iohexol)
125I-iothalamate and 131I-hippuran
Subjects will receive 125I-iothalamate and 131I-hippuran as part of their routine clinical care.
University Medical Centre Groningen, Groningen
University Medical Center Groningen
OTHER